What You Should Know:
- PhaseV, a company at the forefront of applying artificial intelligence (AI) and machine learning (ML) to clinical development raies $50M in Series A funding round co-led by Accel and Insight Partners, with participation from existing investors Viola Ventures, EXOR,
Read More
PhaseV Closes $50M to Advance AI Clinical Development
